![Bruce Landay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bruce Landay
General Counsel at Bio3 Research SRL
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Francesco Paolo Pilato | M | - |
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | 23 years |
Ari Helenius | M | - |
Yale University
| 41 years |
Robert Parker | M | 86 |
Georgetown University
| 38 years |
Donald M. Engelman | M | 83 |
Yale University
| 45 years |
Joseph A. Madri | M | 80 |
Yale University
| 44 years |
Domenico Criscuolo | M | - |
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | - |
Federico Gardini | M | - |
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | - |
Gabriella Messina | F | - |
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | - |
Edoardo BonciNelli | M | - |
Bio3 Research SRL
![]() Bio3 Research SRL Medical SpecialtiesHealth Technology Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Matt Greenfield | M | - |
Yale University
| 16 years |
Paul Pelosi | M | 55 |
Georgetown University
| 8 years |
William J. Schnoor | M | - |
Yale University
| 7 years |
Miguel A. Rodriguez | M | 71 |
Yale University
| 4 years |
Kevin Lavin | M | - |
Georgetown University
| 7 years |
W. Lewis Johnson | M | - |
Yale University
| 5 years |
James Attwood | M | 65 |
Yale University
| 5 years |
Mercer Bullard | M | - |
Georgetown University
Yale University
| 6 years |
Catherine S. Gallagher | F | - |
Georgetown University
Yale University
| 7 years |
John W. Campbell | M | - |
Yale University
| 3 years |
Michael Joseph Chren | M | - |
Yale University
| 4 years |
Robert Glaser | M | 62 |
Yale University
| 4 years |
Martin J. Waters | M | - |
Georgetown University
| 7 years |
Harry Ballan | M | - |
Yale University
| 8 years |
Lawrence T. Yanowitch | M | - |
Georgetown University
| 7 years |
Mark Rosenblatt | M | 65 |
Yale University
| 7 years |
Samer Sami Hassan Joudah | M | 59 |
Georgetown University
| 6 years |
Robert D. Wilder | M | - |
Yale University
| 4 years |
David Ezra Gerstenhaber | M | 63 |
Yale University
| 3 years |
Ron J. Cozean | M | - |
Yale University
| 10 years |
Aaron Kaslow | M | 59 |
Yale University
| 7 years |
Thomas R. Cardello | M | - |
Yale University
| 5 years |
Joseph Gleberman | M | 66 |
Yale University
| 4 years |
Mark Nydam | M | - |
Yale University
| 5 years |
Nils Janson | M | - |
Georgetown University
| 5 years |
Raymond C. Kolls | M | 61 |
Georgetown University
| 7 years |
Jong Han Kim | M | - |
Georgetown University
| 7 years |
Jon Kayyem | M | 60 |
Yale University
| 5 years |
Dean J. Takahashi | M | - |
Yale University
| 5 years |
David F. Swensen | M | 70 |
Yale University
| 4 years |
Carl Ross | M | - |
Georgetown University
| 5 years |
Peter Salovey | M | 66 |
Yale University
| 5 years |
Robert Aiken | M | 61 |
Georgetown University
| 4 years |
Keith D. Grinstein | M | 63 |
Georgetown University
Yale University
| 8 years |
Martin A. Steele | M | - |
Yale University
| 1 years |
Dana Frix | M | - |
Georgetown University
| 4 years |
Tim Johnston | M | 64 |
Yale University
| 4 years |
Albert Rabil | M | 61 |
Yale University
| 4 years |
Rogers M. Smith | M | - |
Yale University
| 21 years |
Don Mullen | M | - |
Yale University
| 4 years |
Shelia Violette | M | - |
Yale University
| 6 years |
Jonathan Trumbull Backus Howe | M | - |
Yale University
| 4 years |
Robin Roger | F | 67 |
Yale University
| 4 years |
Daniel Pullman | M | - |
Yale University
| 4 years |
Jonathan I. Goldstein | M | - |
Yale University
| 4 years |
Brad Jay Simmons | M | 68 |
Yale University
| 4 years |
Kevin L. Olson | M | - |
Yale University
| 3 years |
Amy Schwartz | M | - |
Yale University
| 3 years |
Jorge Avelino Braga de Macedo | M | 77 |
Yale University
| 3 years |
Ram Putcha | M | - |
Yale University
| 2 years |
David L. Douglass | M | - |
Yale University
| 4 years |
Ashwini Kumar Nangia | M | - |
Yale University
| 5 years |
Randolph Sesson | M | 59 |
Yale University
| 4 years |
James A. Giesel | M | - |
Yale University
| 4 years |
Martin Brown | M | 59 |
Yale University
| 4 years |
Mark P. Conley | M | - |
Yale University
| 4 years |
Michelle Collins | F | 63 |
Yale University
| 4 years |
Raul A. Diaz | M | - |
Yale University
| 4 years |
Robert Hazlett | M | - |
Yale University
| 4 years |
William R. Cross | M | - |
Yale University
| 4 years |
Mark Wan | M | 58 |
Yale University
| 4 years |
Warren Lammert | M | - |
Yale University
| 4 years |
Helen Y. Hayes | F | - |
Yale University
| 4 years |
David Singer | M | 61 |
Yale University
| 4 years |
Trace Adair Urdan | M | - |
Yale University
| 4 years |
Joshua Bekenstein | M | 65 |
Yale University
| 4 years |
Mary Easter Pugh | F | 65 |
Yale University
| 4 years |
Hugo Braun | M | - |
Yale University
| 4 years |
Jerry Chafkin | M | 65 |
Yale University
| 4 years |
Peter S. Niculescu | M | 64 |
Yale University
| 3 years |
Julie Edwards | F | 65 |
Yale University
| 4 years |
John R. Cullinane | M | - |
Yale University
| 2 years |
Bridget A. Collins | F | - |
Yale University
| 4 years |
Douglas Kelly | M | - |
Yale University
| 4 years |
Christopher M. Arfaa | M | - |
Yale University
| 4 years |
Ivy Thomas McKinney | F | - |
Yale University
| 3 years |
Susan Morelli | F | - |
Yale University
| 4 years |
Stefan K. Lai | M | - |
Yale University
| 3 years |
Daniel R. Shepard | M | - |
Yale University
| 4 years |
John R. Monsky | M | 65 |
Yale University
| 4 years |
Michael Franc | M | - |
Yale University
| 4 years |
Ned Doubleday | M | - |
Yale University
| 4 years |
Ted Wiese | M | 65 |
Yale University
| 4 years |
Richard L. Siewert | M | 60 |
Yale University
| 4 years |
Elan Ezickson | M | 60 |
Yale University
| 4 years |
Darren Acheson | M | - |
Yale University
| 4 years |
Alan M. Kittner | M | - |
Yale University
| 2 years |
Joe Dannenmaier | M | - |
Yale University
| 4 years |
Steven J. Gavin | M | - |
Yale University
| 4 years |
Kathryn Dominguez | M | - |
Yale University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 94 | 94.95% |
Italy | 5 | 5.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bruce Landay
- Personal Network